Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 11, 2009
Item reduction and psychometric validation of the Oily Skin Self Assessment Scale (OSSAS) and the Oily Skin Impact Scale (OSIS)
Robert Arbuckle, Marci Clark, Jane Harness, et al.
BMC Infectious Diseases
|
August 29, 2014
Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection
Jane Scott, Kathleen Rosa, Min Fu, et al.
Carbohydrate Polymers
|
January 14, 2023
Biofilm inspired fabrication of functional bacterial cellulose through ex-situ and in-situ approaches
Katie A Gilmour, Mahab Aljannat, Christopher Markwell, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 19, 2010
Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics
Matteo Fallani, David Young, Jane Scott, et al.
Influenza and Other Respiratory Viruses
|
September 2, 2021
Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post-discharge assessed by Respiratory Intensity and Impact Questionnaire
Ann R Falsey, Edward E Walsh, Richard H Osborne, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
November 22, 2014
Gender-specific research for emergency diagnosis and management of ischemic heart disease: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup
Basmah Safdar, John T Nagurney, Ayodola Anise, et al.
Plos One
|
July 19, 2016
An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)
Tarik Asselah, Christophe Moreno, Christoph Sarrazin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 19, 2012
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards
Michael Brundage, Jane Blazeby, Dennis Revicki, et al.
Gastroenterology
|
March 8, 2014
Simeprevir with peginterferon and ribavirin leads to high rates of SVR in patients with HCV genotype 1 who relapsed after previous therapy: a phase 3 trial
Xavier Forns, Eric Lawitz, Stefan Zeuzem, et al.
The Lancet. Infectious Diseases
|
December 9, 2014
Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial
K Rajender Reddy, Stefan Zeuzem, Fabien Zoulim, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 11, 2009
Item reduction and psychometric validation of the Oily Skin Self Assessment Scale (OSSAS) and the Oily Skin Impact Scale (OSIS)
Robert Arbuckle, Marci Clark, Jane Harness, et al.
BMC Infectious Diseases
|
August 29, 2014
Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection
Jane Scott, Kathleen Rosa, Min Fu, et al.
Carbohydrate Polymers
|
January 14, 2023
Biofilm inspired fabrication of functional bacterial cellulose through ex-situ and in-situ approaches
Katie A Gilmour, Mahab Aljannat, Christopher Markwell, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 19, 2010
Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics
Matteo Fallani, David Young, Jane Scott, et al.
Influenza and Other Respiratory Viruses
|
September 2, 2021
Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post-discharge assessed by Respiratory Intensity and Impact Questionnaire
Ann R Falsey, Edward E Walsh, Richard H Osborne, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
November 22, 2014
Gender-specific research for emergency diagnosis and management of ischemic heart disease: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup
Basmah Safdar, John T Nagurney, Ayodola Anise, et al.
Plos One
|
July 19, 2016
An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)
Tarik Asselah, Christophe Moreno, Christoph Sarrazin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 19, 2012
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards
Michael Brundage, Jane Blazeby, Dennis Revicki, et al.
Gastroenterology
|
March 8, 2014
Simeprevir with peginterferon and ribavirin leads to high rates of SVR in patients with HCV genotype 1 who relapsed after previous therapy: a phase 3 trial
Xavier Forns, Eric Lawitz, Stefan Zeuzem, et al.
The Lancet. Infectious Diseases
|
December 9, 2014
Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial
K Rajender Reddy, Stefan Zeuzem, Fabien Zoulim, et al.
Page
of 8